These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 6401998)
21. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate. Hornberger W; Patscheke H Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034 [TBL] [Abstract][Full Text] [Related]
22. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Needleman P; Raz A; Ferrendelli JA; Minkes M Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1716-20. PubMed ID: 193113 [TBL] [Abstract][Full Text] [Related]
24. The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals. Cowley AJ; Jones EW; Carter AJ; Hanley SP; Heptinstall S Br J Clin Pharmacol; 1985 Jan; 19(1):1-8. PubMed ID: 2983748 [TBL] [Abstract][Full Text] [Related]
30. The pH dependent platelet utilization of arachidonic acid and a thromboxane A2 mimetic, in vitro. Kerry PJ; Paton CJ Pharmacol Res Commun; 1985 Jul; 17(7):609-18. PubMed ID: 3931104 [TBL] [Abstract][Full Text] [Related]
32. Different effects of thromboxane synthetase inhibitors on platelets from different individuals. Lancet; 1982 Nov; 2(8308):1156-7. PubMed ID: 6128469 [No Abstract] [Full Text] [Related]
33. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets. Rao AK; Koike K; Day HJ; Smith JB; Holmsen H Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822 [TBL] [Abstract][Full Text] [Related]
34. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R; Mezzasoma AM; Venditti G; Gresele P Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [TBL] [Abstract][Full Text] [Related]
35. Irreversible inhibition of thromboxane (TX) A2 synthesis by Y-20811, a selective TX synthetase inhibitor. Mikashima H; Ochi H; Muramoto Y; Hirotsu K; Arima N Biochem Pharmacol; 1992 Jan; 43(2):295-9. PubMed ID: 1739418 [TBL] [Abstract][Full Text] [Related]
36. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588 [TBL] [Abstract][Full Text] [Related]
37. Dazoxiben examined for platelet inhibitory effect in an artificial circulation. Goldman M; Hall C; Hawker RJ; McCollum CN Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):61S-65S. PubMed ID: 6681706 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway. Tobias LD; Hamilton JG Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605 [No Abstract] [Full Text] [Related]
39. UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Randall MJ; Parry MJ; Hawkeswood E; Cross PE; Dickinson RP Thromb Res; 1981 Jul 1-15; 23(1-2):145-62. PubMed ID: 6795753 [No Abstract] [Full Text] [Related]
40. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]